Clinical-Grade Bio-Defense for Modern Healthcare

Moving Beyond Barriers to Active Pathogen Inactivation.

Hospital room with two beds, medical equipment, a desk with a black bag, and framed floral art on the wall.

Traditional medical textiles act as passive barriers that merely trap pathogens. DURITex™ transforms surfaces into active shields, neutralizing >99.9% of bacteria and viruses—including SARS-CoV-2—on contact.

Closing the Gap in Clinical Hygiene.

Close-up of a patient with an IV line in their hand lying in a hospital bed.
A shield-shaped logo with two shades of blue and the text 'DURITex' in white.

Continuous Self-Decontamination for Patient Safety.

While standard laundering removes visible dirt, it offers no defense against immediate re-contamination. DURITex™ transforms medical linens into active surfaces that fight pathogens between cleanings.

The Clinical Proof (RODAC Validation):

  • 0 CFU Hospital Performance: In third-party clinical trials (UiTM-A&A Lab Reports CN 0194/0289), DURITex™ treated textiles—including bed sheets, baby wrappers, and OT linens—returned a Zero CFU count for aggressive pathogens like Bacillus cereus.

  • SARS-CoV-2 Inactivation: Validated by the University of Texas Medical Branch (UTMB), our technology actively neutralizes viral threats on fabric surfaces, significantly reducing the risk of cross-contamination for healthcare workers and patients.

  • Fungal Mitigation: Field-validated over 28-day cycles to prevent "bio-nesting," ensuring that medical linens stored in high-humidity facility closets remain sterile and odor-free.

  • Industrial Durability: Formulated to withstand 100+ industrial-grade washes without losing antimicrobial efficacy.

Applications Across the Facility

Integrating Science into Every Fiber

  • Patient Care: Bed linens, privacy curtains, and patient gowns that self-sanitize between changes.

  • Staff Safety: Lab coats, scrubs, and high-filtration masks that protect the wearer and the environment.

  • Facility Infrastructure: HVAC filtration treatment to neutralize airborne pathogens and improve Indoor Air Quality (IAQ).

A healthcare professional making a bed in a hospital room.

DURITex™ Healthcare Validation

A chart comparing different testing standards for pathogens and their validated results. The chart includes UTMB Lab Study for SARS-CoV-2 with over 99% inactivation, AATCC 100 for MRSA and Staph with over 99.9% kill rate, ASTM G21 for fungi and mold showing zero growth, and ISO 10993-10 for human skin indicating non-sensitizing and non-irritating properties.

Bring DURITex™ to Your Facility.